Bank Of Hawaii Abb Vie Inc. Transaction History

Bank Of Hawaii

$2.38 Billion
Q3 2024

A detailed history of Bank Of Hawaii transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of Hawaii holds 31,831 shares of ABBV stock, worth $5.63 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

31,831

Previous 32,646 2.5%

Holding current value

$5.63 Million

Previous $5.6 Million 12.25%

% of portfolio

0.26%

Previous 0.26%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $133,529 - $162,453	-815 Reduced 2.5%	31,831 $6.29 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $173,364 - $202,451	-1,120 Reduced 3.32%	32,646 $5.6 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $332,745 - $379,132	-2,082 Reduced 5.81%	33,766 $6.15 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $260,339 - $293,203	-1,892 Reduced 5.01%	35,848 $5.56 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $162,044 - $187,590	-1,213 Reduced 3.11%	37,740 $5.63 Million
Q2 2023 Aug 09, 2023	SELL	$132.51 - $164.9 $1.29 Million - $1.61 Million	-9,753 Reduced 20.02%	38,953 $5.25 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $14,461 - $16,654	-100 Reduced 0.2%	48,706 $7.76 Million
Q4 2022 Jan 30, 2023	BUY	$138.31 - $165.87 $647,705 - $776,769	4,683 Added 10.61%	48,806 $7.89 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $764,728 - $877,093	5,698 Added 14.83%	44,123 $5.92 Million
Q2 2022 Aug 11, 2022	SELL	$137.62 - $174.96 $82,984 - $105,500	-603 Reduced 1.55%	38,425 $5.89 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $44,081 - $54,692	-334 Reduced 0.85%	39,028 $6.33 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $687,229 - $869,544	-6,397 Reduced 13.98%	39,362 $5.33 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $572,751 - $650,158	-5,383 Reduced 10.53%	45,759 $4.94 Million
Q2 2021 Jul 22, 2021	SELL	$105.21 - $117.21 $255,239 - $284,351	-2,426 Reduced 4.53%	51,142 $5.76 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $212,067 - $233,461	-2,073 Reduced 3.73%	53,568 $5.8 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $901,568 - $1.22 Million	-11,201 Reduced 16.76%	55,641 $5.96 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $245,101 - $287,667	-2,853 Reduced 4.09%	66,842 $5.86 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $455,994 - $610,188	-6,215 Reduced 8.19%	69,695 $6.84 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $222,138 - $336,788	-3,444 Reduced 4.34%	75,910 $5.78 Million
Q4 2019 Feb 12, 2020	SELL	$72.13 - $90.25 $931,486 - $1.17 Million	-12,914 Reduced 14.0%	79,354 $7.03 Million
Q3 2019 Nov 15, 2019	SELL	$62.98 - $75.72 $683,521 - $821,789	-10,853 Reduced 10.52%	92,268 $6.99 Million
Q2 2019 Aug 15, 2019	SELL	$65.7 - $83.98 $30,879 - $39,470	-470 Reduced 0.45%	103,121 $7.5 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $8,716 - $10,259	-113 Reduced 0.11%	103,591 $8.35 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $314,825 - $388,264	-4,044 Reduced 3.75%	103,704 $9.56 Million
Q3 2018 Nov 09, 2018	SELL	$88.91 - $98.84 $140,922 - $156,661	-1,585 Reduced 1.45%	107,748 $10.2 Million
Q2 2018 Aug 06, 2018	BUY	$89.78 - $106.23 $24,869 - $29,425	277 Added 0.25%	109,333 $10.1 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $47,201 - $63,206	513 Added 0.47%	109,056 $10.3 Million
Q4 2017 Feb 12, 2018	SELL	$89.56 - $98.21 $618,053 - $677,747	-6,901 Reduced 5.98%	108,543 $10.5 Million
Q3 2017 Nov 03, 2017	SELL	$69.85 - $89.22 $1.56 Million - $1.99 Million	-22,360 Reduced 16.23%	115,444 $10.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	137,804	137,804 $9.99 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.

Account